X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (20304) 20304
Newsletter (671) 671
Book Chapter (322) 322
Newspaper Article (257) 257
Magazine Article (175) 175
Transcript (40) 40
Book / eBook (36) 36
Dissertation (25) 25
Web Resource (15) 15
Conference Proceeding (14) 14
Trade Publication Article (12) 12
Reference (4) 4
Publication (3) 3
Book Review (2) 2
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (15131) 15131
science & technology (14636) 14636
life sciences & biomedicine (13139) 13139
proteases (6304) 6304
male (6054) 6054
hiv infections - drug therapy (5657) 5657
animals (5419) 5419
female (5385) 5385
protease inhibitors (5072) 5072
hiv protease inhibitors - therapeutic use (4660) 4660
adult (4004) 4004
protease inhibitors - therapeutic use (3393) 3393
pharmacology & pharmacy (3213) 3213
middle aged (3115) 3115
infectious diseases (2914) 2914
anti-hiv agents - therapeutic use (2763) 2763
drug therapy, combination (2750) 2750
hiv (2516) 2516
aids/hiv (2396) 2396
proteins (2340) 2340
immunology (2294) 2294
research (2221) 2221
health aspects (2186) 2186
protease inhibitors - pharmacology (1970) 1970
analysis (1963) 1963
mice (1884) 1884
biochemistry & molecular biology (1874) 1874
reverse transcriptase inhibitors - therapeutic use (1828) 1828
hiv infections - virology (1802) 1802
virology (1767) 1767
treatment outcome (1728) 1728
viral load (1690) 1690
drug therapy (1685) 1685
protease (1634) 1634
research article (1542) 1542
hiv protease inhibitors - adverse effects (1420) 1420
antiviral agents (1390) 1390
microbiology (1387) 1387
medicine (1383) 1383
care and treatment (1379) 1379
hiv-1 - drug effects (1374) 1374
science & technology - other topics (1356) 1356
aged (1332) 1332
ritonavir - therapeutic use (1317) 1317
multidisciplinary sciences (1310) 1310
enzymes (1296) 1296
cell biology (1294) 1294
oncology (1291) 1291
cd4 lymphocyte count (1284) 1284
mutation (1266) 1266
physiological aspects (1264) 1264
antiviral agents - therapeutic use (1213) 1213
hiv protease inhibitors - administration & dosage (1179) 1179
cancer (1150) 1150
abridged index medicus (1134) 1134
hiv infection (1115) 1115
science (1110) 1110
hiv-1 - genetics (1088) 1088
human immunodeficiency virus--hiv (1055) 1055
rats (1055) 1055
apoptosis (1037) 1037
hiv protease inhibitors - pharmacology (1027) 1027
highly active antiretroviral therapy (998) 998
antiretroviral therapy, highly active (966) 966
aids (954) 954
gene expression (932) 932
risk factors (925) 925
genetic aspects (920) 920
genotype (917) 917
drug resistance (915) 915
peptides (881) 881
drug interactions (867) 867
inflammation (862) 862
chemistry (857) 857
biochemistry (852) 852
adolescent (850) 850
hiv-1 (850) 850
clinical trials as topic (825) 825
proteinase inhibitors (822) 822
time factors (820) 820
biology (804) 804
proteolysis (799) 799
viruses (795) 795
antiretroviral therapy (770) 770
medical research (765) 765
hiv infections - complications (764) 764
hepatitis c virus (761) 761
antiretroviral drugs (760) 760
cell line, tumor (758) 758
hiv infections - immunology (753) 753
physical sciences (745) 745
hepatitis c (744) 744
medicine & public health (738) 738
protease inhibitor (736) 736
hiv protease inhibitors - pharmacokinetics (730) 730
rna, viral - blood (729) 729
virus diseases (727) 727
amino acid sequence (684) 684
life sciences (670) 670
bortezomib (661) 661
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (21002) 21002
Russian (218) 218
Spanish (209) 209
German (203) 203
French (169) 169
Japanese (160) 160
Portuguese (60) 60
Italian (33) 33
Chinese (28) 28
Polish (28) 28
Dutch (17) 17
Hungarian (12) 12
Danish (8) 8
Ukrainian (8) 8
Czech (6) 6
Swedish (4) 4
Turkish (4) 4
Finnish (3) 3
Norwegian (3) 3
Bulgarian (2) 2
Croatian (2) 2
Hebrew (2) 2
Lithuanian (2) 2
Romanian (2) 2
Serbian (2) 2
Slovak (2) 2
Arabic (1) 1
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Best Practice & Research: Clinical Endocrinology & Metabolism, ISSN 1521-690X, 2007, Volume 21, Issue 4, pp. 517 - 533
.... Several DPP-4 inhibitors are in clinical development. Most experience so far has been with sitagliptin (Merck... 
Endocrinology & Metabolism | treatment | dipeptidyl peptidase 4 | sitagliptin | type-2 diabetes | vildagliptin | glucagon-like peptide-1 | Life Sciences & Biomedicine | Science & Technology | Triazoles - adverse effects | Metformin - therapeutic use | Humans | Body Weight - drug effects | Pyrrolidines - adverse effects | Substrate Specificity | Glucagon-Like Peptide 1 - physiology | Pyrazines - therapeutic use | Pyrrolidines - therapeutic use | Thiazolidinediones - therapeutic use | Adamantane - therapeutic use | Sitagliptin Phosphate | Drug Therapy, Combination | Hypoglycemia - chemically induced | Protease Inhibitors - therapeutic use | Insulin Secretion | Adamantane - adverse effects | Adamantane - analogs & derivatives | Triazoles - therapeutic use | Hypoglycemic Agents - therapeutic use | Pioglitazone | Insulin - metabolism | Animals | Dipeptidyl-Peptidase IV Inhibitors | Lipid Metabolism - drug effects | Pyrazines - adverse effects | Glucagon - metabolism | Vildagliptin | Glucagon-Like Peptide 1 - antagonists & inhibitors | Diabetes Mellitus, Type 2 - drug therapy | Nitriles - adverse effects | Insulin - therapeutic use | Nitriles - therapeutic use | Index Medicus | Clinical Medicine | Other Clinical Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | Adamantane/adverse effects Adamantane/analogs & derivatives Adamantane/therapeutic use Animals Antigens | Annan klinisk medicin | Combination Glucagon/secretion Glucagon-Like Peptide 1/antagonists & inhibitors Glucagon-Like Peptide 1/physiology Humans Hypoglycemia/chemically induced Hypoglycemic Agents/therapeutic use Insulin/secretion Insulin/therapeutic use Lipid Metabolism/drug effects Metformin/therapeutic use Nitriles/adverse effects Nitriles/therapeutic use Protease Inhibitors/therapeutic use Pyrazines/adverse effects Pyrazines/therapeutic use Pyrrolidines/adverse effects Pyrrolidines/therapeutic use Substrate Specificity Thiazolidinediones/therapeutic use Triazoles/adverse effects Triazoles/therapeutic use | Type 2/drug therapy Drug Therapy | Klinisk medicin | CD26/antagonists & inhibitors Body Weight/drug effects Diabetes Mellitus
Journal Article
The Journal of infectious diseases, ISSN 1537-6613, 10/2015, Volume 212, Issue 8, pp. 1241 - 1249
Journal Article
The Lancet infectious diseases, ISSN 1473-3099, 07/2015, Volume 15, Issue 7, pp. 775 - 784
Journal Article
Journal Article
Annals of internal medicine, ISSN 0003-4819, 2012, Volume 156, Issue 4, pp. 279 - 290
Journal Article
Drugs, ISSN 0012-6667, 2003, Volume 63, Issue 19, pp. 1973 - 1998
... with therapeutic potential.These new drugs include aids to smoking cessation (e.g. bupropion) and improvements to existing therapies, for example long-acting rather than short-acting bronchodilators, as well as combination therapy... 
Tumour necrosis factor antagonists, therapeutic us | Mitogen activated protein kinase inhibitors, thera | Beta 2 adrenoceptor agonists, therapeutic use | Chronic obstructive pulmonary disease, treatment | Acetylcholine receptor antagonists, therapeutic us | Smoking withdrawal, treatment | Research and development | Nitric oxide synthase inhibitors, therapeutic use | Leukotriene B4 antagonists, therapeutic use | Interleukin 10, therapeutic use | Leucocyte elastase inhibitors, therapeutic use | Phosphodiesterase inhibitors, therapeutic use | Cyclo oxygenase 2 inhibitors, therapeutic use | Protease inhibitors, therapeutic use | Adenosine A2 receptor agonists, therapeutic use | Mucolytics, therapeutic use | Anti inflammatories, therapeutic use | Antioxidants, therapeutic use | Chemokine antagonists, therapeutic use | Sibenadet, therapeutic use | Adhesion molecule antagonists, therapeutic use | Metalloproteinase inhibitors, therapeutic use | NF kappa B Decoy, therapeutic use | Bronchodilators, therapeutic use | Smoking cessation therapies, therapeutic use | Theophylline, therapeutic use | Neurokinin antagonists, therapeutic use | Retinoids, therapeutic use | Corticosteroids, therapeutic use | P2Y2 receptor agonists, therapeutic use | Cysteine protease inhibitors, therapeutic use | Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Pharmacology & Pharmacy | Toxicology | Life Sciences & Biomedicine | Science & Technology | Clinical Trials as Topic | Pulmonary Disease, Chronic Obstructive - physiopathology | Humans | Pulmonary Disease, Chronic Obstructive - drug therapy | Index Medicus
Journal Article